CRISPR: Pursuit of profit poisons collaboration

Nature

Volumn 532, Issue 7598, 2016, Pages 172-173

  Sherkow, Jacob S ^a  

^a NEW YORK LAW SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRISPR CAS SYSTEM; GENE EXPRESSION; GOVERNMENT; HUMAN; HUMAN EMBRYONIC STEM CELL; INVESTMENT; LAW; MEDICAL RESEARCH; MEDICAL SOCIETY; NON PROFIT ORGANIZATION; NOTE; PATENT; PRIORITY JOURNAL; PUBLICATION; RNA EDITING; RNA INTERFERENCE; RNA SPLICING; COOPERATION; ECONOMICS; GENETICS; INVENTION; LEGISLATION AND JURISPRUDENCE; LICENSING; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PRENATAL DIAGNOSIS; TECHNOLOGY; TIME FACTOR; UNIVERSITY;

SMALL INTERFERING RNA;

ACADEMIES AND INSTITUTES; COOPERATIVE BEHAVIOR; CRISPR-CAS SYSTEMS; INVENTIONS; LICENSURE; OWNERSHIP; PATENTS AS TOPIC; PRENATAL DIAGNOSIS; RNA, SMALL INTERFERING; TECHNOLOGY TRANSFER; TIME FACTORS; UNIVERSITIES;

EID: 84964430131     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/532172a     Document Type: Note

References (7)

1. Association of University Technology Managers. AUTM US Licensing Activity Survey: FY2014 (AUTM, 2014).
2. Lander, E. S. Cell 164, 18-28 (2016).
3. Abrams, I., Leung, G. & Stevens, A. J. Res. Mgmt. Rev. 17, 18-50 (2009).
4. Association of University Technology Managers. AUTM US Licensing Survey: FY1999 (AUTM, 1999).
5. Sherkow, J. S. Nature Biotechnol. 33, 256-257 (2015).
6. Eisenberg, R. S. Houston Law Rev. 45, 1059-1099 (2008).
7. Feldman, R. & Price, N. W. II Stanford Tech. Law Rev. 17, 773-808 (2014).